295 related articles for article (PubMed ID: 31281569)
21. Empagliflozin attenuates diabetic tubulopathy by improving mitochondrial fragmentation and autophagy.
Lee YH; Kim SH; Kang JM; Heo JH; Kim DJ; Park SH; Sung M; Kim J; Oh J; Yang DH; Lee SH; Lee SY
Am J Physiol Renal Physiol; 2019 Oct; 317(4):F767-F780. PubMed ID: 31390268
[TBL] [Abstract][Full Text] [Related]
22. Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis.
Su K; Yi B; Yao BQ; Xia T; Yang YF; Zhang ZH; Chen C
Pharmacol Res; 2020 Jun; 156():104778. PubMed ID: 32247822
[TBL] [Abstract][Full Text] [Related]
23. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
24. Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1α pathway.
Ding M; Feng N; Tang D; Feng J; Li Z; Jia M; Liu Z; Gu X; Wang Y; Fu F; Pei J
J Pineal Res; 2018 Sep; 65(2):e12491. PubMed ID: 29575122
[TBL] [Abstract][Full Text] [Related]
25. IGF2BP3-stabilized CAMK1 regulates the mitochondrial dynamics of renal tubule to alleviate diabetic nephropathy.
Yuan D; Li H; Dai W; Zhou X; Zhou W; He L
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167022. PubMed ID: 38216068
[TBL] [Abstract][Full Text] [Related]
26. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
Qu X; Zhai B; Liu Y; Chen Y; Xie Z; Wang Q; Wu Y; Liu Z; Chen J; Mei S; Wu J; You Z; Yu Y; Wang Y
Biomed Pharmacother; 2022 Jun; 150():112998. PubMed ID: 35489281
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy.
Jiang XS; Xiang XY; Chen XM; He JL; Liu T; Gan H; Du XG
Cell Death Dis; 2020 May; 11(5):385. PubMed ID: 32439839
[TBL] [Abstract][Full Text] [Related]
28. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1.
Xiao L; Xu X; Zhang F; Wang M; Xu Y; Tang D; Wang J; Qin Y; Liu Y; Tang C; He L; Greka A; Zhou Z; Liu F; Dong Z; Sun L
Redox Biol; 2017 Apr; 11():297-311. PubMed ID: 28033563
[TBL] [Abstract][Full Text] [Related]
29. Mangiferin Alleviates Renal Interstitial Fibrosis in Streptozotocin-Induced Diabetic Mice through Regulating the PTEN/PI3K/Akt Signaling Pathway.
Song Y; Liu W; Tang K; Zang J; Li D; Gao H
J Diabetes Res; 2020; 2020():9481720. PubMed ID: 32076626
[TBL] [Abstract][Full Text] [Related]
30. Chloroquine and amodiaquine enhance AMPK phosphorylation and improve mitochondrial fragmentation in diabetic tubulopathy.
Jeong HY; Kang JM; Jun HH; Kim DJ; Park SH; Sung MJ; Heo JH; Yang DH; Lee SH; Lee SY
Sci Rep; 2018 Jun; 8(1):8774. PubMed ID: 29884802
[TBL] [Abstract][Full Text] [Related]
31. Mitochondria-targeted peptide SS-31 attenuates renal injury via an antioxidant effect in diabetic nephropathy.
Hou Y; Li S; Wu M; Wei J; Ren Y; Du C; Wu H; Han C; Duan H; Shi Y
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F547-59. PubMed ID: 26719366
[TBL] [Abstract][Full Text] [Related]
32. Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.
Ninichuk V; Kulkarni O; Clauss S; Anders H-
Eur J Med Res; 2007 Aug; 12(8):351-5. PubMed ID: 17933712
[TBL] [Abstract][Full Text] [Related]
33. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress mediated mitochondrial damage plays roles in pathogenesis of diabetic nephropathy rat.
Chen X; Fang M
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5248-5254. PubMed ID: 30178848
[TBL] [Abstract][Full Text] [Related]
35. ATF5 regulates tubulointerstitial injury in diabetic kidney disease via mitochondrial unfolded protein response.
Liu Y; Zhang L; Zhang S; Liu J; Li X; Yang K; Yang D; Liu Y; Sun L; Liu F; Xiao L
Mol Med; 2023 Apr; 29(1):57. PubMed ID: 37095454
[TBL] [Abstract][Full Text] [Related]
36. Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis.
Jia J; Tan R; Xu L; Wang H; Li J; Su H; Zhong X; Liu P; Wang L
Int Immunopharmacol; 2024 Jun; 135():112303. PubMed ID: 38776855
[TBL] [Abstract][Full Text] [Related]
37. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
[TBL] [Abstract][Full Text] [Related]
38. Polydatin impairs mitochondria fitness and ameliorates podocyte injury by suppressing Drp1 expression.
Ni Z; Tao L; Xiaohui X; Zelin Z; Jiangang L; Zhao S; Weikang H; Hongchao X; Qiujing W; Xin L
J Cell Physiol; 2017 Oct; 232(10):2776-2787. PubMed ID: 28383775
[TBL] [Abstract][Full Text] [Related]
39. Mitochondrial activity contributes to impaired renal metabolic homeostasis and renal pathology in STZ-induced diabetic mice.
Wu M; Li S; Yu X; Chen W; Ma H; Shao C; Zhang Y; Zhang A; Huang S; Jia Z
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F593-F605. PubMed ID: 31268353
[TBL] [Abstract][Full Text] [Related]
40. Dencichine ameliorates renal injury by improving oxidative stress, apoptosis and fibrosis in diabetic rats.
Huang C; Cheng L; Feng X; Li X; Wang L
Life Sci; 2020 Oct; 258():118146. PubMed ID: 32721462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
